Evidence map›Paper›PMID 40806639›Full record

ArticleInternational journal of molecular sciences2025

Rapid Change in FcεRI Occupancy on Basophils After Venom Immunotherapy Induction.

Viktoria Puxkandl, Stefan Aigner, Teresa Burner, Angelika Lackner, Sherezade Moñino-Romero, Susanne Kimeswenger, Wolfram Hoetzenecker, Sabine Altrichter

Abstract read
In one paragraph

Article in International journal of molecular sciences, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Viktoria PuxkandlDepartment for Dermatology and Venerology, Kepler University Hospital, 4020 Linz, Austria.ORCID 0000-0002-0090-8866
Stefan AignerDepartment for Dermatology and Venerology, Kepler University Hospital, 4020 Linz, Austria.ORCID 0009-0003-1285-1662
Teresa BurnerDepartment for Dermatology and Venerology, Kepler University Hospital, 4020 Linz, Austria.
Angelika LacknerDepartment for Dermatology and Venerology, Kepler University Hospital, 4020 Linz, Austria.
Sherezade Moñino-RomeroInstitute of Allergology, Charité-Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin, Humboldt-Universität zu Berlin, 10117 Berlin, Germany.
Susanne KimeswengerDepartment for Dermatology and Venerology, Kepler University Hospital, 4020 Linz, Austria.
Wolfram HoetzeneckerDepartment for Dermatology and Venerology, Kepler University Hospital, 4020 Linz, Austria.
Sabine AltrichterDepartment for Dermatology and Venerology, Kepler University Hospital, 4020 Linz, Austria.ORCID 0000-0001-9955-385X

Funding

Johannes Kepler University Linz Impetus I-05-22 METOI
6 · The paper itself

Abstract

Specific venom immunotherapy (VIT) in patients with hymenoptera venom allergy (HVA) represents a well-studied approach to reduce the severity of a possible anaphylactic reaction. Currently, data on mechanisms of tolerance induction at the cellular level within the first hours of therapy are lacking. To address this, total and unoccupied high-affinity IgE receptor (FcεRI) numbers per basophil, soluble FcεRI (sFcεRI) and serum tryptase levels were measured before and after the first day of VIT induction in HVA patients. Additionally, basophil activation tests (BATs) were performed at those time points. In the early phase of VIT induction, no significant change in total FcεRI receptor density on basophils was observed, but a significant increase in unoccupied FcεRI was noticeable, predominantly in patients with high total IgE and low baseline unoccupied FcεRI density. No meaningful difference in serum tryptase levels or sFcεRI levels was observed after VIT induction. BATs showed heterogeneous results, often unchanged before and after VIT (in 47% of the cases), sometimes increased (in 40%) and only rarely decreased EC

Indexed as

Arthropod VenomsBasophilsDesensitization, ImmunologicHypersensitivityReceptors, IgEAdultAnaphylaxisAnimalsFemaleHumansHymenopteraImmunoglobulin EMaleMiddle AgedTryptasesYoung AdultArthropod VenomsImmunoglobulin EReceptors, IgETryptasesbasophil activation testbasophilsbeeFcεRIhymenopteraIgEspecific immunotherapysubcutaneous injectionvenom allergywasp

Identifiers

PMID40806639
PMCPMC12346946

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.